Product Information
DEXTROAMP-AMPHETAMINE 5 MG TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2640 per EA under NDC 68462064701. Its NADAC has been published 61 times since Jun 25, 2025.
FDA first approved this application on Jul 5, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHETAMINE 5 MG TAB
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine SulfateStrength
1.25; 1.25; 1.25; 1.25 mg/1; mg/1; mg/1; mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462064701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE DL-ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA210754FDA Approved
7/5/2022
TE Code
AB
On Market Since
5/12/2025
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHETAMINE 5 MG TAB has been published 61 times since Jun 25, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2640 per EA |
|---|---|
| All-time high | $0.2765 (Aug 13, 2025) |
| All-time low | $0.2386 (Mar 18, 2026) |
| 52-week high | $0.2728 |
| 52-week low | $0.2386 |
| Median price | $0.2595 |
| Average price | $0.2561 |
| Largest weekly change | +7.1% (May 20, 2026) |
| Weeks tracked | 61 |
| Tracking since | Jun 25, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHETAMINE 5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMINE 5 MG TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2640 per EA (NDC 68462064701), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHETAMINE 5 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMINE 5 MG TAB has held within roughly two percent of its current level. It has been tracked across 61 weekly CMS publications since Jun 25, 2025.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMINE 5 MG TAB?
Since Jun 25, 2025, the NADAC for DEXTROAMP-AMPHETAMINE 5 MG TAB has ranged from a low of $0.2386 (Mar 18, 2026) to a high of $0.2765 (Aug 13, 2025), with a median of $0.2595 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHETAMINE 5 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMP-AMPHETAMINE 5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXTROAMP-AMPHETAMINE 5 MG TAB?
DEXTROAMP-AMPHETAMINE 5 MG TAB (NDC 68462064701) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.